Surgical Robots Market 2030: Analyzing the Rising Demand for Robot-Assisted Neurosurgery

The global market for surgical robots was valued at approximately USD 3.92 billion in 2023, and it is projected to experience a significant expansion with a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030. Several key factors are fueling this growth, including a worldwide shortage of trained physicians and surgeons, as well as the growing adoption of automated surgical instruments. In addition, the increasing prevalence of bone degenerative diseases, combined with a higher incidence of hip and knee replacement surgeries-often due to conditions such as arthritis and osteoporosis-is expected to further drive the demand for surgical robots. For instance, the Agency for Healthcare Research and Quality reports that over 450,000 hip replacement surgeries are performed annually in the United States alone.

The rise in knee and hip replacement surgeries is a critical factor that is likely to accelerate the use of surgical robots in the healthcare industry. Common conditions such as arthritis, degenerative bone diseases, and osteoporosis are significantly contributing to the increasing number of patients needing joint replacement surgeries. As the number of individuals affected by these conditions continues to grow, the demand for robotic-assisted procedures is expected to rise correspondingly.

Gather more insights about the market drivers, restrains and growth of the Surgical Robots Market

Application Segmentation Insights

In 2023, the “Other Applications” segment, which includes the use of surgical robots in oncology, laparoscopy, and other general surgical operations, accounted for the largest revenue share of 44.76%. This segment’s dominant market share can be attributed to the growing use of surgical robots in cancer treatment, as well as the increasing demand for minimally invasive laparoscopic surgeries. Both of these factors are driving the expansion of this segment within the global surgical robotics market.

Meanwhile, the neurology segment is anticipated to register the fastest CAGR of 17.6% between 2024 and 2030. This growth can be attributed to the rising adoption of robotic technologies in neurosurgery, which offers distinct advantages over traditional surgical methods. Neurosurgery is considered one of the most delicate and complex surgical specialties due to the precision required in small, confined surgical areas. Robotic-assisted surgery, with its enhanced accuracy and ability to perform minimally invasive procedures, is gaining popularity in this field. Factors such as the increasing prevalence of neurological disorders and the growing demand for minimally invasive techniques for delicate brain surgeries are further contributing to the segment’s expansion. For example, the ROSA ONE Brain robotic platform is widely used by surgeons in performing minimally invasive brain procedures, highlighting the growing role of robotics in neurosurgical interventions.

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.